Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: borredo

Sorry, but that post was directed to Fatwollit, and with regard to your post.

Perhaps the question that remains (besides the relevance of market cap) is: will the numbers from a settlement (assuming they are announced) be enough to enable forecasts of future licensing revenues? You suggested that this number PLUS numbers from some settlements that follow (which probably won't be announced with the signings) will allow a realistic P/E. I wondering if the settlement amount alone will do the trick. I'm thinking it will, and it will be based on an extraordinary number (especially sense I consider $200M a low-ball number).

As I've said before, it will definitely be interesting to see what happens - and maybe just a little bit exciting to boot!

I KNOW nuttin'!

SGE

Share
New Message
Please login to post a reply